Astrana Health, Inc.
ASTH
$29.56
-$1.82-5.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -156.26% | -27.04% | 45.57% | 12.97% | 431.44% |
| Total Depreciation and Amortization | 65.77% | 68.73% | 75.12% | 18.73% | 20.65% |
| Total Amortization of Deferred Charges | 29.71% | 92.83% | 93.67% | 93.25% | 48.31% |
| Total Other Non-Cash Items | 213.66% | -48.67% | 323.34% | -2.88% | -531.35% |
| Change in Net Operating Assets | -277.81% | 107.49% | -315.71% | -22.23% | -79.47% |
| Cash from Operations | -156.73% | 120.58% | -10.13% | -22.58% | -77.28% |
| Capital Expenditure | 64.13% | 44.09% | -12.72% | 97.52% | -696.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,573.88% | 81.91% | -18,367.43% | -- | 82.88% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.93% | 80.96% | -335.53% | -2,553.55% | -110.20% |
| Cash from Investing | -191.63% | 76.75% | -1,441.17% | -406.16% | -186.56% |
| Total Debt Issued | -100.00% | 9.89% | 51,455.56% | 6,702.72% | 17,355.21% |
| Total Debt Repaid | 93.92% | -1,017.38% | -2,394.48% | -1,098.37% | -69,184.75% |
| Issuance of Common Stock | 92.28% | -- | -- | -- | -95.65% |
| Repurchase of Common Stock | -80.32% | -638.67% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -4,317.13% |
| Other Financing Activities | 50.46% | -125.89% | -133.29% | 125.00% | -1,361.95% |
| Cash from Financing | -227.30% | -525.49% | 5,006.75% | 1,598.11% | 104.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -399.70% | 213.53% | -148.26% | 407.81% | -80.90% |